Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies.

IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM International Journal of Endocrinology and Metabolism Pub Date : 2022-07-19 eCollection Date: 2022-07-01 DOI:10.5812/ijem-120949
Sima Nazarpour, Mina Amiri, Razieh Bidhendi Yarandi, Fereidoun Azizi, Fahimeh Ramezani Tehrani
{"title":"Maternal Subclinical Hyperthyroidism and Adverse Pregnancy Outcomes: A Systematic Review and Meta-analysis of Observational Studies.","authors":"Sima Nazarpour,&nbsp;Mina Amiri,&nbsp;Razieh Bidhendi Yarandi,&nbsp;Fereidoun Azizi,&nbsp;Fahimeh Ramezani Tehrani","doi":"10.5812/ijem-120949","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Findings from studies evaluating adverse pregnancy outcomes in pregnant women with subclinical hyperthyroidism are conflicting and inconclusive.</p><p><strong>Objectives: </strong>In this systematic review and meta-analysis, our aim was to evaluate the pooled odds ratio (OR) of adverse pregnancy outcomes in women with subclinical hyperthyroidism, compared to euthyroid women.</p><p><strong>Data sources: </strong>Scopus, PubMed (including Medline), and Web of Science databases were systemically searched for regaining published studies to January 2022 examining adverse pregnancy outcomes in women with subclinical hyperthyroidism.</p><p><strong>Study selection: </strong>Outcomes of interest were classified into seven composite outcomes, including hypertensive disorders, preterm delivery, macrosomia/large for gestational age (LGA), pregnancy loss, adverse maternal outcomes, adverse neonatal outcomes, and adverse fetal outcomes.</p><p><strong>Data extraction: </strong>In this meta-analysis, both fixed and random effect models were used. Publication bias was also evaluated by Egger test and the funnel plot, and the trim and fill method was conducted in case of a significant result, to adjust the bias.</p><p><strong>Results: </strong>Of 202 records retrieved through searching databases, 11 studies were selected for the final analyses. There were no significant differences in pooled ORs of hypertensive disorders, preterm delivery, macrosomia/LGA, and pregnancy loss in pregnant women with subclinical hyperthyroidism, compared to the euthyroid controls. The pooled OR of adverse maternal, neonatal, and fetal outcomes in pregnant women with subclinical hyperthyroidism was not statistically significantly different from that of the euthyroid control group.</p><p><strong>Conclusions: </strong>The current meta-analysis demonstrated that subclinical hyperthyroidism in pregnancy is not related with adverse maternal and fetal outcomes. Therefore, clinicians should be avoided unnecessary treatments for pregnant women with subclinical hyperthyroidism.</p>","PeriodicalId":13969,"journal":{"name":"International Journal of Endocrinology and Metabolism","volume":"20 3","pages":"e120949"},"PeriodicalIF":2.1000,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d5/aa/ijem-20-3-120949.PMC9675093.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology and Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5812/ijem-120949","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

Context: Findings from studies evaluating adverse pregnancy outcomes in pregnant women with subclinical hyperthyroidism are conflicting and inconclusive.

Objectives: In this systematic review and meta-analysis, our aim was to evaluate the pooled odds ratio (OR) of adverse pregnancy outcomes in women with subclinical hyperthyroidism, compared to euthyroid women.

Data sources: Scopus, PubMed (including Medline), and Web of Science databases were systemically searched for regaining published studies to January 2022 examining adverse pregnancy outcomes in women with subclinical hyperthyroidism.

Study selection: Outcomes of interest were classified into seven composite outcomes, including hypertensive disorders, preterm delivery, macrosomia/large for gestational age (LGA), pregnancy loss, adverse maternal outcomes, adverse neonatal outcomes, and adverse fetal outcomes.

Data extraction: In this meta-analysis, both fixed and random effect models were used. Publication bias was also evaluated by Egger test and the funnel plot, and the trim and fill method was conducted in case of a significant result, to adjust the bias.

Results: Of 202 records retrieved through searching databases, 11 studies were selected for the final analyses. There were no significant differences in pooled ORs of hypertensive disorders, preterm delivery, macrosomia/LGA, and pregnancy loss in pregnant women with subclinical hyperthyroidism, compared to the euthyroid controls. The pooled OR of adverse maternal, neonatal, and fetal outcomes in pregnant women with subclinical hyperthyroidism was not statistically significantly different from that of the euthyroid control group.

Conclusions: The current meta-analysis demonstrated that subclinical hyperthyroidism in pregnancy is not related with adverse maternal and fetal outcomes. Therefore, clinicians should be avoided unnecessary treatments for pregnant women with subclinical hyperthyroidism.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
母亲亚临床甲状腺功能亢进和不良妊娠结局:观察性研究的系统回顾和荟萃分析。
背景:评估亚临床甲状腺功能亢进孕妇不良妊娠结局的研究结果是相互矛盾和不确定的。目的:在这项系统回顾和荟萃分析中,我们的目的是评估亚临床甲状腺功能亢进妇女与甲状腺功能正常妇女的不良妊娠结局的合并优势比(OR)。数据来源:系统检索Scopus、PubMed(包括Medline)和Web of Science数据库,检索截至2022年1月已发表的研究,研究亚临床甲状腺功能亢进妇女的不良妊娠结局。研究选择:关注的结局被分为7个复合结局,包括高血压疾病、早产、巨大儿/大胎龄儿(LGA)、妊娠丢失、孕产妇不良结局、新生儿不良结局和胎儿不良结局。数据提取:本meta分析采用固定效应模型和随机效应模型。采用Egger检验和漏斗图评价发表偏倚,结果显著时采用修剪填充法调整偏倚。结果:从检索数据库检索到的202份文献中,筛选出11份文献进行最终分析。与甲状腺功能正常的对照组相比,亚临床甲状腺功能亢进孕妇高血压疾病、早产、巨大儿/LGA和妊娠丢失的总or值无显著差异。亚临床甲状腺功能亢进孕妇的不良产妇、新生儿和胎儿结局的总OR与甲状腺功能正常对照组相比无统计学差异。结论:目前的荟萃分析表明,妊娠亚临床甲状腺功能亢进与母体和胎儿的不良结局无关。因此,临床医生应避免对亚临床甲亢孕妇进行不必要的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.10
自引率
4.80%
发文量
0
期刊介绍: The aim of the International Journal of Endocrinology and Metabolism (IJEM) is to increase knowledge, stimulate research in the field of endocrinology, and promote better management of patients with endocrinological disorders. To achieve this goal, the journal publishes original research papers on human, animal and cell culture studies relevant to endocrinology.
期刊最新文献
Primary Hyperaldosteronism in a Normotensive Patient: A Case Report What About My Weight? Insufficient Weight Loss or Weight Regain After Bariatric Metabolic Surgery Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome Bioinformatic Identification of Hub Genes Related to Menopause-Obesity Paradox in Breast Cancer Type 1 Diabetes and COVID-19: A Literature Review and Possible Management
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1